Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Investig Med High Impact Case Rep ; 10: 23247096211051928, 2022.
Article in English | MEDLINE | ID: mdl-35225034

ABSTRACT

A 49-year-old man with no significant past medical history received dexamethasone as part of his treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Less than 3 weeks later, the patient developed acute respiratory distress syndrome. Radiological and serological testing led to a diagnosis of acute hypoxic miliary coccidioidomycosis. A 52-year-old man with a past medical history of chronic kidney disease (CKD) was treated with prednisone for focal segmental glomerulosclerosis (FSGS). Within 2 weeks, this patient developed bilateral lower extremity weakness. Radiology, serology, and lumbar puncture proved a diagnosis of reactivated coccidioidomycosis with miliary pattern and coccidioidomycosis meningoencephalitis with arachnoiditis. Whether treatment with glucocorticoids caused reactivation of coccidioidomycosis is discussed in this case series.


Subject(s)
COVID-19 Drug Treatment , Coccidioidomycosis , Respiratory Distress Syndrome , Coccidioidomycosis/diagnosis , Coccidioidomycosis/drug therapy , Glucocorticoids/adverse effects , Humans , Male , Middle Aged , Respiratory Distress Syndrome/chemically induced , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL
...